WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.
“Company”) will present at the 35th>Annual
J.P. Morgan Healthcare Conference in San Francisco, California at
3:30 PM Pacific Time.
conference will be available through the Investors link at the
Company’s website, http://www.westpharma.com,>and is also
attached hereto as Exhibit 99.1 and incorporated herein by
reference.
furnished to Item 7.01 and shall not be deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (“Exchange Act”), or otherwise subject to the
liabilities of that section, nor will it be incorporated by
reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as expressly set forth by
specific referencing in such filing.
|
(d)
|
Exhibit No.
|
Description
|
|
|
Exhibit 99.1
|
West Pharmaceutical Services, Inc. Investor Presentation.
|
About WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST)
West Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Company’s segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). Its Packaging Systems segment includes primary packaging components and systems for injectable drug delivery, other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. Its Delivery Systems segment includes safety and administration systems, multi-component systems for drug containment and administration and various custom contract-manufacturing solutions. WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) Recent Trading Information
WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) closed its last trading session down -0.20 at 87.50 with 508,089 shares trading hands.
